Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.
Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.
Exiqon signed the agreement with Health Research, a non-profit corporation affiliated with RPCI and the New York State Department of Health whose mission is to evaluate, solicit, and administer external financial support for projects and facilitate technology transfer, according to the company's website.
The agreement is the latest under Exiqon's certified service provider program. In August, Exiqon established a similar COE at the Oncogenomics Core Facility in the University of Miami School of Medicine (PCR Insider, 8/23/11).
Also, in June, Exiqon named Sweden's Tataa Biocenter and South Korea's Bioneer as COEs; and in November 2009 the company named Harvard University's ICCB-Longwood Screening Facility as a microRNA screening COE.